Landscapes / Companies

Neurocrine Biosciences not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
2 in Phase 3
Next date
NBI-1065890, Phase 2 trial completes
Drugs
9
in active trials · 19 in all
Trials
19 active
63 since 2021

Drugs9

DrugHow it worksPartnerStageNext dateDetails
—
Approved Mar 2028Phase 2 trial completes
—
Approved Apr 2028Phase 3 trial completes
—
Phase 3 Jul 2027Phase 3 trial completes
—
Phase 3 Oct 2027Phase 3 trial completes
—
Phase 2 Feb 2027Phase 2 trial completes
—
Phase 2 Aug 2027Phase 2 trial completes
—
Phase 2 16 Mar 2028Phase 2 trial completes
—
Phase 2 May 2028Phase 2 trial completes
NBIB-0000223not checked
—
Phase 1 Nov 2028Phase 1 trial completes

About

No active trial
10 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Neurocrine Biosciences

Following is part of Solo: you see every change to Neurocrine Biosciences the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in